Separation Systems for Commercial Biotechnology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Separation Systems 
for Commercial 
Biotechnology Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  t he  la t es t  repor t  by  I MARC Group,  t i t l ed  "Separat ion  Systems fo r  
Commercia l  Bi o techno logy  Market :  G loba l  I ndust ry  T rends ,  Share ,  S i ze ,  
Growth ,  Opportun i ty  and  Forecast  2024-2032, "  t he  g loba l  separa t ion  sys t ems 
fo r  commerc ia l  b io t echno logy  marke t  s i ze  reached  US$ 26 .8  B i l l i on  in  2023.
Report Separa t ion  sys tem s fo r  comm erc ia l  b io techno logy  are  so lu t i ons  used t o  pu r i f y  and  separa t e  b io log i ca l  p roduc ts  f rom comp lex  m ix t u res  and  so lu t ions  such  as  
d iagnos t i c  reagent s ,  b iochemica ls ,  and  b iopharmaceut i ca l s .  I t  i nc ludes  va r ious  
Highlight and equ ipmen t  and dev ices ,  such  as  membranes ,  f i l t e r s ,  cen t r i f uges ,  chromat og raphs ,  
b ioch ips ,  and  m ic roa r rays .  
Description These  so lu t ions  a lso  o f fe r  var ious  bene f i t s ,  such  as  h igher  recovery  and  m in ima l  was te  genera t ion .  Owing  t o  these  p roper t ies ,  separa t ion  sys tem s f ind  ex t ens ive  
app l i ca t ions  ac ross  pharmaceu t i ca l ,  f ood  and  beverage  (F&B) ,  cosmet i c ,  and  
ag r i cu l t u re  i ndus t r ies .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/separa t ion -sys t ems- fo r -comm erc ia l - b i o t echno logy -m
arke t / reques t samp le
Report Description
Global  Separat ion  Systems for  Commerc ia l  Biotechnology  Marke t  Trends :
The marke t  i s  p r ima r i l y  d r iven  by  the  expand ing  pharmaceu t ica l  i ndus t ry .  I n  add i t ion ,  t he  esca la t ing  demand fo r  
pe rsona l ized  d rugs ,  b iopharmaceu t ica ls ,  and  ce l l -based  the rap ies  due  to  the  inc reas ing  p reva lence  o f  ch ron ic  
med ica l  a i lmen ts  rep resen ts  ano ther  ma jo r  g rowth - induc ing  fac to r .  
Bes ides  th is ,  va r ious  techno log ica l  advancemen ts ,  i nc lud ing  the  deve lopment  o f  i nnova t i ve  ups t ream 
b iop rocess ing  techno log ies  tha t  e l im ina te  b iohaza rdous  by -p roduc ts  us ing  s imp l i f ied  p rocedures ,  a re  con t r ibu t ing  
to  the  marke t  g rowth .  Moreover ,  t he  improv ing  hea l thcare  in f ras t ruc tu re ,  espec ia l l y  in  deve lop ing  coun t r ies ,  and  
ex tens ive  research  and  deve lopment  (R&D)  in  the  f i e ld  o f  b io techno logy  a re  a lso  c rea t ing  a  pos i t i ve  marke t  
ou t look  ac ross  the  g lobe .
Look ing  forward,  IMARC Group expects  the  market  va lue  to  reach US$  42 .9  B i l l ion  by  2032 ,  exhib i t ing a  
CAGR of  5 .24% dur ing  the  forecas t  per iod (2024-2032) .
V iew Report  TOC,  F igures  and Tab les :  
h t tps : / /www. imarcgroup.com/separat ion-systems-for -commerc ia l -b iotechnology-market
Breakup by Methods:
• Modern Methods
o Microarray
o Lab-on-a-Chip
o Magnet ic Separat ion
o Others
• Convent ional  Methods
Report o Chromatography
o Flow Cytometry
Segmentation
o Membrane Fi l trat ion
o Others
 
Breakup by Application:
• Pharmaceut ical
o Vaccines
o Proteins
o Hormones and Insul in
o Enzymes
o Human Blood Plasma Fract ionat ion
o Mammalian Cel l  Cultures
o Pharmaceutical
• Food and Cosmetics
• Agriculture
Report • Others
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in America
• Middle East and Afr ica
• Agi lent Technologies Inc.
• Becton Dickinson and Company
• Bio-Rad Laboratories Inc.
• Hitachi  Ltd.
Competitive 
• Merck KGaA
Landscape • Pal l  Corporat ion (Danaher Corporation)
with Key • PerkinElmer Inc.
• Qiagen N.V
Players
• Repl igen Corporat ion
• Sartorius AG
• Shimadzu Corporation
• Thermo Fisher Scient ifi c
What was the size of the global separation systems for 
commercial biotechnology market in 2023?
What is the expected growth rate of the global separation 
systems for commercial biotechnology market during 2024-
2032?
What are the key factors driving the global separation 
Key systems for commercial biotechnology market?
Questions What has been the impact of COVID-19 on the global separation systems for commercial biotechnology market?
Answered in 
What is the breakup of the global separation systems for 
commercial biotechnology market based on the methods?
the Report
What is the breakup of the global separation systems for 
commercial biotechnology market based on the application?
What are the key regions in the global separation systems 
for commercial biotechnology market?
Who are the key players/companies in the global separation 
systems for commercial biotechnology market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  S e p a r a t i o n  S y s t e m s  f o r  C o m m e r c i a l  B i o t e c h n o l o g y  M a r k e t    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  M e t h o d s
    6 . 1     M o d e r n  M e t h o d s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  M i c r o a r r a y
           6 . 1 . 2 . 2  L a b - o n - a - C h i p
           6 . 1 . 2 . 3  M a g n e t i c  S e p a r a t i o n
           6 . 1 . 2 . 4  O t h e r s
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     C o n v e n t i o n a l  M e t h o d s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
       
           6 . 2 . 2 . 1  C h r o m a t o g r a p h y
           6 . 2 . 2 . 2  F l o w  C y t o m e t r y
           6 . 2 . 2 . 3  M e m b r a n e  F i l t r a t i o n
           6 . 2 . 2 . 4  O t h e r s
        6 . 2 . 3  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    7 . 1     P h a r m a c e u t i c a l
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  K e y  S e g m e n t s
           7 . 1 . 2 . 1  V a c c i n e s
           7 . 1 . 2 . 2  P r o t e i n s
           7 . 1 . 2 . 3  H o r m o n e s  a n d  I n s u l i n
Table of            7 . 1 . 2 . 4  E n z y m e s
           7 . 1 . 2 . 5  H u m a n  B l o o d  P l a s m a  F r a c t i o n a t i o n
           7 . 1 . 2 . 6  M a m m a l i a n  C e l l  C u l t u r e s
Contents         7 . 1 . 3  M a r k e t  F o r e c a s t    7 . 2     F o o d  a n d  C o s m e t i c s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     A g r i c u l t u r e
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     O t h e r s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  R e g i o n
    8 . 1     N o r t h  A m e r i c a
        8 . 1 . 1  U n i t e d  S t a t e s
           8 . 1 . 1 . 1  M a r k e t  T r e n d s
           8 . 1 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / s e p a r a t i o n - s y s t em s - f o r- co m m erc i a l
- b i o t ec h n o l o g y - ma r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: